EverHint – EMA10 × EMA30 Crossover – Top 10 Buy and Top 4 Sell Signals for Apr 09, 2026
14 signals (from 136 total). Financial Services leads (36). 22 with insider selling. 3 with insider buying. 6 with congressional buying. 3 with congressional selling. RSI 24-90. sectors: Financial Services (36), Industrials (17), Technology (15). 8 report earnings within 7 days
EverHint – EMA10 × EMA30 Crossover – Top 10 Buy and Top 10 Sell Signals for Mar 24, 2026
20 signals (from 51 total). Technology leads (15). 12 with insider selling. 1 with insider buying. 4 with congressional buying. 3 with congressional selling. price range $2-$5208. RSI 13-72. sectors: Technology (15), Industrials (10), Healthcare (7). 2 report earnings within 7 days. 33.3% have news.
EverHint - How Stock Splits Affect Technical Indicators: AMCR 1:5 Reverse Split Case Study
AMCR's 1:5 reverse split demonstrates how corporate actions impact SMA200, SMA50, and RSI14. Historical prices adjust proportionally, preserving indicator relationships, but the ±7 day exclusion window remains critical for avoiding false signals
EverHint Signal — Dip & Bounce — December 17, 2025
6 dip-bounce signals with controlled intraday flushes. QLYS led with 3.97% dip + 2.96% bounce recovery. SRRK shows massive +$12.7M insider buying during the dip (bullish). Mean reversion setups on -1.2% market selloff day.
EverHint Signal — EMA10 × EMA30 Crossover — December 15, 2025
EMA10 × EMA30 crossover scanner flagged 19 buy and 26 sell signals on December 15, 2025, with buys clustered in consumer cyclicals and industrials while sells skew toward tech and energy. Most names sit above 200-day trends with mixed insider flows and Q1–Q2 2026 earnings ahead.
EverHint Signal — EMA10 × EMA30 Crossover — December 11, 2025
Seventy-one stocks triggered EMA10×EMA30 crossovers on December 11, with 59 buy signals led by oversold tech and financials. Twelve sell signals flagged weakening momentum in healthcare and utilities. Booz Allen's CEO bought $2M worth of shares during recent weakness.
